Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Irlanda-1-Association for Common Cold in Children
NCT02656888Phase 3Withdrawn
- Sponsor
- EMS
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in common cold comparing Irlanda-1-Association with Placebo (2 arms). Primary endpoint: Efficacy of Irlanda-1-Association in the treatment of common cold symptoms at 7 days. Planned start Jun 2019; status: withdrawn.
02
Drugs
Desloratadine + phenylephrine + ibuprofen
03
Conditions
common cold
Beyond the preview
Go deeper on NCT02656888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656888.